Cargando…
Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms
Metformin treatment is associated with a decreased risk and better prognosis of pancreatic cancer (PC) in patients with type 2 diabetes, but the mechanism of metformin’s PC growth inhibition in the context of a prediabetic state is unknown. We used a Panc02 pancreatic tumor cell transplant model in...
Autores principales: | Cifarelli, Vincenza, Lashinger, Laura M., Devlin, Kaylyn L., Dunlap, Sarah M., Huang, Jennifer, Kaaks, Rudolf, Pollak, Michael N., Hursting, Stephen D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407853/ https://www.ncbi.nlm.nih.gov/pubmed/25576058 http://dx.doi.org/10.2337/db14-1132 |
Ejemplares similares
-
Stage-Specific MicroRNAs and Their Role in the Anticancer Effects of Calorie Restriction in a Rat Model of ER-Positive Luminal Breast Cancer
por: Devlin, Kaylyn L., et al.
Publicado: (2016) -
Using NIH-ADOPT Process to Characterize Adolescents with Obesity and Prediabetes
por: Arce, Britney, et al.
Publicado: (2022) -
Calorie restriction and cancer prevention: a mechanistic perspective
por: Hursting, Stephen D, et al.
Publicado: (2013) -
MON-LB102 Metformin-Induced Weight Loss in Patients With or Without Type 2 Diabetes/Prediabetes
por: Chukir, Tariq, et al.
Publicado: (2020) -
Predicting risk of substantial weight gain in German adults—a multi-center cohort approach
por: Bachlechner, Ursula, et al.
Publicado: (2017)